Literature DB >> 11302800

Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.

P López1, J Gavaldà, M T Martin, B Almirante, X Gomis, C Azuaje, N Borrell, L Pou, V Falcó, C Pigrau, A Pahissa.   

Abstract

With the aim of investigating home therapy for enterococcal endocarditis, we compared the efficacy of teicoplanin combined with gentamicin given once a day or in three daily doses (t.i.d.) with the standard treatment, ampicillin plus gentamicin administered t.i.d., for treating experimental enterococcal endocarditis. The antibiotics were administered by using "human-like pharmacokinetics" (H-L), i.e, pharmacokinetics like those in humans, that simulated the profiles of these drugs in human serum. Animals with catheter-induced endocarditis were infected intravenously with 10(8) CFU of Enterococcus faecalis EF91 (MICs and MBCs of ampicillin, gentamicin, and teicoplanin, 0.5 and 32, 16 and 32, and 0.5 and 1 microg/ml, respectively) and were treated for 3 days with ampicillin H-L at 2 g every 4 h plus gentamicin H-L at 1 mg/kg every 8 h, or teicoplanin H-L at 10 mg/kg every 24 h, alone or combined with gentamicin, administered at dose of H-L at 1 mg/kg every 8 h or H-L at 4.5 mg/kg every 24 h. The results of therapy for experimental endocarditis due to EF91 showed that teicoplanin alone was as effective as ampicillin alone in reducing the bacterial load (P > 0.05). The combination of ampicillin or teicoplanin with gentamicin was more effective than the administration of both drugs alone in reducing the log(10)CFU/gram of aortic vegetation (P < 0.01 and P < 0.05, respectively). Teicoplanin plus gentamicin H-L at 4.5 mg/kg, both administered every 24 h, showed an efficacy equal to the "gold standard," ampicillin plus gentamicin H-L at 1 mg/kg t.i.d. (P > 0.05). Increasing the interval of administration of gentamicin to a single daily dose combined with teicoplanin resulted in a reduction of bacteria in the vegetations equivalent to that achieved with the recommended regimen of ampicillin plus thrice-daily gentamicin in the treatment of experimental endocarditis due to E. faecalis. Teicoplanin plus gentamicin, both administered once a day, may be useful home therapy for selected cases of enterococcal endocarditis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302800      PMCID: PMC90478          DOI: 10.1128/AAC.45.5.1387-1393.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.

Authors:  H F Chambers; S Kennedy
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

2.  Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.

Authors:  J Gavaldà; A Pahissa; B Almirante; M Laguarda; E Crespo; L Pou; F Fernández
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

3.  Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.

Authors:  A U Gerber; T Stritzko; C Segessenmann; B Stalder
Journal:  Scand J Infect Dis Suppl       Date:  1990

5.  Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.

Authors:  J E Leggett; S Ebert; B Fantin; W A Craig
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.

Authors:  M Blatter; U Fluckiger; J Entenza; M P Glauser; P Francioli
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria.

Authors:  E Presterl; W Graninger; A Georgopoulos
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

8.  Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.

Authors:  P B Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

9.  Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.

Authors:  A Saleh-Mghir; A C Cremieux; J M Vallois; M Muffat-Joly; C Devine; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  Teicoplanin in the treatment of gram-positive-bacterial endocarditis.

Authors:  P Martino; M Venditti; A Micozzi; C Brandimarte; G Gentile; C Santini; P Serra
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

View more
  4 in total

1.  Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model.

Authors:  Laurent Dubé; Jocelyne Caillon; Christèle Gras-Le Guen; Cédric Jacqueline; Marie-France Kergueris; Jean-Claude Granry; Gilles Potel; Denis Bugnon
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.

Authors:  L Dubé; J Caillon; C Jacqueline; D Bugnon; G Potel; N Asseray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-08       Impact factor: 3.267

3.  Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.

Authors:  Joan Gavaldà; Pedro López; Teresa Martín; Xavier Gomis; José Luis Ramírez; Carlos Azuaje; Benito Almirante; Albert Pahissa
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 4.  Intrinsic and acquired resistance mechanisms in enterococcus.

Authors:  Brian L Hollenbeck; Louis B Rice
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.